Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Yerly

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Immunology|May 16, 2012
Avidity determines T-cell reactivity in abacavir hypersensitivityJacqueline Adam, Klara K Eriksson, Benno Schnyder, et al.
Rheumatology (Oxford, England)|March 28, 2019
Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritisSabine Adler, Stephan Reichenbach, Andrea Gloor, et al.
Die Anaesthesiologie|December 10, 2024
Anaphylactic shock with cardiac arrest triggered by tranexamic acid : A case report and review of the literatureAndrina Neff, Anna Grünewald, Andrei Korbut, et al.
Rheumatology (Oxford, England)|July 3, 2018
Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritisAndrea D Gloor, Daniel Yerly, Sabine Adler, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 24, 2022
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccinesFlorian Stehlin, Francesco Tommasini, Véronique Monzambani-Banderet, et al.
Arthritis Research & Therapy|January 23, 2016
Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritisManuela Tham, Gabriele R Schlör, Daniel Yerly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2014
Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01James Yun, Maria J Marcaida, Klara K Eriksson, et al.
The American Journal of Pathology|April 16, 2014
T cells infiltrate the liver and kill hepatocytes in HLA-B(∗)57:01-associated floxacillin-induced liver injuryNatascha Wuillemin, Luigi Terracciano, Helmut Beltraminelli, et al.
Plos One|April 23, 2014
Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responsesJacqueline Adam, Natascha Wuillemin, Stephan Watkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopesDaniel Yerly, David Heckerman, Todd Allen, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Immunology|May 16, 2012
Avidity determines T-cell reactivity in abacavir hypersensitivityJacqueline Adam, Klara K Eriksson, Benno Schnyder, et al.
Rheumatology (Oxford, England)|March 28, 2019
Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritisSabine Adler, Stephan Reichenbach, Andrea Gloor, et al.
Die Anaesthesiologie|December 10, 2024
Anaphylactic shock with cardiac arrest triggered by tranexamic acid : A case report and review of the literatureAndrina Neff, Anna Grünewald, Andrei Korbut, et al.
Rheumatology (Oxford, England)|July 3, 2018
Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritisAndrea D Gloor, Daniel Yerly, Sabine Adler, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 24, 2022
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccinesFlorian Stehlin, Francesco Tommasini, Véronique Monzambani-Banderet, et al.
Arthritis Research & Therapy|January 23, 2016
Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritisManuela Tham, Gabriele R Schlör, Daniel Yerly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2014
Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01James Yun, Maria J Marcaida, Klara K Eriksson, et al.
The American Journal of Pathology|April 16, 2014
T cells infiltrate the liver and kill hepatocytes in HLA-B(∗)57:01-associated floxacillin-induced liver injuryNatascha Wuillemin, Luigi Terracciano, Helmut Beltraminelli, et al.
Plos One|April 23, 2014
Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responsesJacqueline Adam, Natascha Wuillemin, Stephan Watkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopesDaniel Yerly, David Heckerman, Todd Allen, et al.
Pageof 5